Achieve Life Sciences, Inc. SC 13D and SC 13D/A reports

Location
22722 29 Th Dr. Se, Suite 100, Seattle, WA
State of incorporation
DE
Fiscal year end
December 31
Data updated at
11/7/2024, 04:19 PM
Form type Sec Links Description Filing date Reporting date
SC 13D/A Report AMENDMENT NO. 2 TO THE SCHEDULE 13D Mar 23, 2023
SC 13D/A Report AMENDMENT NO. 1 TO THE SCHEDULE 13D Mar 6, 2023
SC 13D Report SCHEDULE 13D Jan 20, 2023
SC 13D Report SC 13D Aug 11, 2017
SC 13D Report SC 13D Aug 11, 2017
SC 13D/A Report ONCOGENEX PHARMACEUTICALS 13DA Feb 14, 2011
SC 13D/A Report SCHEDULE 13D AMENDMENT NO. 1 Oct 28, 2010
SC 13D Report SCHEDULE 13D Aug 20, 2010